Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This approach to skin barrier protection utilizes zinc oxide and bismuth oxide (bismuth oxychloride) as physical barriers against UV radiation and irritants. Additionally, astringents help reduce inflammation and exudation, while emollients moisturize and soften the skin. These agents work synergistically to reinforce the skin's natural protective function, prevent moisture loss, and soothe irritation.
Physical barrier preventing UV radiation and irritant exposure; moisture retention through occlusion; astringent action to soothe inflammation; emollient effect to soften skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin Barrier Protection via Zinc Oxide, Bismuth Oxide, Astringency, and Emollient Effect.